Pharmacology for Nurses · Introduction to Cancer Therapy and Cancer Drugs
Chemotherapeutic Drugs
On this page 9 sections
In 30 seconds
Chemotherapy is the use of drugs to treat cancer. Most classic chemotherapeutic drugs are Cytotoxic Cell-damaging; kills or injures cells Full entry →: they damage or kill cells, preferentially cancer cells, because cancer cells divide far more often than most healthy cells. That preference is only partial — the same drugs damage healthy tissues that also divide rapidly: bone marrow, the lining of the mouth and digestive tract, and hair follicles. This fact explains nearly every common side effect.
To make sense of chemotherapy, start with the Cell cycle The sequence of phases a cell goes through to divide Full entry →: a cell rests in G0, prepares in G1, copies DNA in S phase, prepares again in G2, and divides in M phase (mitosis). Some drugs work only while cells are actively dividing (cell-cycle–specific); others damage cells even at rest (cell-cycle–nonspecific). Because a tumor holds cells at many points in the cycle, treatment combines drugs with different mechanisms — combination chemotherapy.
Why this matters
- Chemotherapy drugs are high-alert medications that nurses prepare, administer, and monitor — mechanisms and toxicities are a direct patient-safety issue.
- Side effects are predictable from the cell-cycle concept — which tissues divide fast tells you which toxicities to anticipate and teach.
- Nursing care (infection precautions, oral care, symptom management, safe handling) is a major part of successful treatment.
- Exams routinely pair a drug class with its mechanism, hallmark toxicity, or nursing consideration.
The college version
Core Concepts
The Cell Cycle: Where Chemotherapy Strikes
The cell cycle has four active phases plus a resting state: G0 (resting), G1 (growth), S phase (DNA copied), G2 (final prep), and M phase (mitosis — division). Cell-cycle–specific drugs (antimetabolites, vinca alkaloids, taxanes) work only against actively cycling cells — best for tumors with a high growth fraction. Cell-cycle–nonspecific drugs (alkylating agents, platinum compounds, antitumor antibiotics) damage cells in any phase, including resting cells — why they anchor most regimens.
Major Drug Classes and Mechanisms
| Class | Mechanism | Example drugs | Cycle profile |
|---|---|---|---|
| Alkylating agents | Attach alkyl groups to DNA and cross-link strands, blocking replication | cyclophosphamide, ifosfamide, busulfan | Nonspecific |
| Platinum analogs | Form cross-links within and between DNA strands | cisplatin, carboplatin, oxaliplatin | Nonspecific |
| Antimetabolites | Mimic building blocks; block enzymes needed for DNA/RNA synthesis | methotrexate, fluorouracil, mercaptopurine | S-phase specific |
| Antitumor antibiotics | Intercalate into DNA and/or inhibit topoisomerase | doxorubicin (anthracycline), bleomycin | Nonspecific |
| Microtubule inhibitors | Disrupt the mitotic spindle so chromosomes cannot separate | vincristine, vinblastine; paclitaxel, docetaxel | M-phase specific |
| Topoisomerase inhibitors | Block enzymes that uncoil DNA during replication | etoposide, irinotecan, topotecan | S-phase dependent |
Each class carries characteristic organ toxicities: anthracyclines → heart, bleomycin → lungs, cisplatin → kidneys and hearing, vinca alkaloids → peripheral neuropathy. These are class-level patterns; individual risk varies, so always verify against current references, the institutional formulary, and prescriber orders.
Combination Therapy: Why More Than One Drug
Tumors are genetically diverse — some cells are already resistant to any single drug. Combinations attack from several directions: different mechanisms (a DNA-damaging drug plus a metabolic blocker is hard to defeat with one mutation), different cell-cycle coverage (nonspecific plus S-phase–specific drugs hit dividing and resting cells alike), and limited overlapping toxicity. Regimens go by acronyms (e.g., CHOP for lymphoma); the specific drugs, doses, and schedule come from the current treatment protocol.
Why Adverse Effects Happen
Healthy tissues that divide fast are damaged too. Bone marrow suppression (Myelosuppression Reduced blood-cell production in the bone marrow Full entry →) lowers white cells (neutropenia — infection risk), platelets (thrombocytopenia — bleeding risk), and red cells (anemia — fatigue); counts bottom out ("Nadir The lowest point blood counts reach after treatment Full entry →") days after treatment. GI lining damage causes nausea, vomiting, mucositis, and diarrhea; hair follicles produce temporary alopecia. Two situations are urgent: extravasation — a Vesicant A drug that damages tissue if it leaks from the vein Full entry → (e.g., an anthracycline or vinca alkaloid) leaks from the IV site and must be reported immediately — and Tumor lysis syndrome Rapid breakdown of many tumor cells flooding the blood with cell contents Full entry →, when rapid destruction of a large tumor floods the blood with potassium, phosphate, and uric acid, injuring kidneys and disturbing heart rhythm. Monitoring parameters and interventions belong to the institutional protocol and current references.
Nursing Implications for Safe Care
- Safe handling: chemotherapy is hazardous to everyone who touches it; PPE, prep areas, spill kits, and disposal follow facility policy, which varies by institution.
- Pre-treatment: confirm identity and the correct drug/regimen per prescriber orders and the current protocol; check blood counts and organ function.
- Monitoring: fever in neutropenia is a priority symptom — report immediately; also watch for bruising or bleeding, mouth pain, and changes in urination or breathing.
- Education: explain expected side effects and their timeline, when to call, infection precautions, oral hygiene, hydration, and safe handling of body fluids at home.
- Language and scope: use person-first phrasing ("a person receiving chemotherapy"); preparation and administration scope varies by state and institution.
Common Confusions
| Do not confuse | With | Difference |
|---|---|---|
| Chemotherapy = IV drugs only | Oral, intrathecal, and intraperitoneal chemotherapy | Route depends on the drug and disease; many agents are oral |
| Antimetabolites kill cells in any phase | Antimetabolites as S-phase–specific | They only work while DNA is being synthesized — a classic exam trap |
| All chemotherapy causes hair loss | Alopecia varies by drug | Not every agent causes alopecia; severity depends on the drug and dose |
| Chemotherapy = all cancer drugs | Targeted and biologic therapies (topics 3–4) | Different mechanisms and toxicity profiles |
| Nausea is expected, so no action is needed | Nausea as preventable and manageable | Modern antiemetic protocols prevent much of it; uncontrolled nausea must be reported |

Eli explains
The same idea, in plain words
Explain it like I’m 10
Cancer cells copy themselves over and over, way faster than normal cells. Chemotherapy drugs are like a wrench thrown into the copying machine — they jam the parts that let cells duplicate. Healthy cells that also copy fast — making blood, hair, and the inside of your mouth — use the same parts. That's why people getting chemo get tired, lose hair, and feel sick: the wrench hits fast copiers everywhere, not just the cancer.
Worked example
A person newly diagnosed with non-Hodgkin lymphoma is starting a combination regimen containing an alkylating agent, an anthracycline, a vinca alkaloid, and a corticosteroid. The cell-cycle concept predicts:
- Predict the toxicities. The alkylator and anthracycline suppress the bone marrow — fatigue and a window of increased infection risk. The vinca alkaloid raises peripheral neuropathy risk (tingling in hands and feet); the corticosteroid can affect sleep, appetite, and blood sugar.
- Plan the teaching. Counts fall after treatment and recover before the next cycle; report fever, bleeding, mouth sores, or new tingling right away. Teach temperature-taking, hand hygiene, and mouth care.
- Prepare for the infusion. Confirm drugs, doses, and sequence against prescriber orders and the current protocol; check counts and organ function; have the extravasation kit ready per facility policy.
- Document and follow up. Record baseline symptoms and vitals, monitor for reactions, and give written "call us if…" criteria before discharge.
Key takeaways
- Chemotherapy is cytotoxic — selectivity for rapidly dividing cancer cells is only partial, explaining predictable toxicities in marrow, GI lining, and hair follicles.
- Cell-cycle–specific: antimetabolites (S phase), vinca alkaloids and taxanes (M phase). Nonspecific: alkylators, platinum, anthracyclines.
- Class–toxicity triads: anthracyclines → cardiotoxicity; bleomycin → pulmonary toxicity; cisplatin → nephro/ototoxicity; vinca alkaloids → neuropathy.
- Myelosuppression is the most common dose-limiting toxicity; neutropenic fever is a priority symptom.
- Extravasation and tumor lysis syndrome are urgent events — report immediately, follow institutional protocol.
- Always verify drugs, doses, and protocols against current references, the formulary, and prescriber orders.
Check yourself
5 review questions from the chapter. Try each one, then open the answer.
A drug that damages DNA regardless of the cell's phase is cell-cycle–specific or nonspecific? Give an example class.
Show answer
Nonspecific. Alkylating agents and platinum compounds are classic examples (antitumor antibiotics act across phases too).
Why do chemotherapy side effects so often involve the bone marrow, GI lining, and hair follicles?
Show answer
Those tissues contain rapidly dividing cells, and chemotherapy's selectivity for fast-dividing cancer cells is only partial — healthy fast-dividing cells are damaged too.
Which cell-cycle phase does each target: antimetabolites; vinca alkaloids and taxanes?
Show answer
Antimetabolites target S phase (DNA synthesis); vinca alkaloids and taxanes target M phase (mitosis, via the microtubule spindle).
What is the rationale for giving several chemotherapy drugs together?
Show answer
Tumors contain genetically diverse cells, some already resistant to any single drug; combinations attack different mechanisms, cover different cell-cycle phases, and limit overlapping toxicities.
A person receiving chemotherapy reports a fever. Why is this a priority symptom, and what should the nurse do first?
Show answer
Fever may signal neutropenic infection, which can become life-threatening quickly. Notify the care team immediately and follow the facility's neutropenic-fever protocol — always per current protocol and prescriber orders.
Study tools & related lessonsKey vocabulary · Related
Key vocabulary
- Cytotoxic
- Cell-damaging; kills or injures cells
- Cell cycle
- The sequence of phases a cell goes through to divide
- Cell-cycle–specific drug
- Effective mainly against cells dividing in a particular phase
- Cell-cycle–nonspecific drug
- Damages cells in any phase, including resting
- Myelosuppression
- Reduced blood-cell production in the bone marrow
- Nadir
- The lowest point blood counts reach after treatment
- Vesicant
- A drug that damages tissue if it leaks from the vein
- Tumor lysis syndrome
- Rapid breakdown of many tumor cells flooding the blood with cell contents
Sources & references
This lesson was adapted from the open educational references above; their licenses and attributions are preserved. See Copyright & Licensing.
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

